Legality of Cannabis by U.S. Jurisdiction

Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
WikiCleanerBot (talk | contribs)
Bots
864,077 edits
m v2.05b - Bot T20 CW#61 - Fix errors for CW project (Reference before punctuation)
Tags: WPCleaner Reverted
Restored revision 1212732714 by Xoak (talk): Accusations add undue weight to BLP. The investigation findings aren't yet published, until then he's presumed innocent
Line 7: Line 7:
| alt = Head and shoulders photo of Mamun Al Mahtab
| alt = Head and shoulders photo of Mamun Al Mahtab
| caption = Al Mahtab in 2021
| caption = Al Mahtab in 2021
| birth_date = {{birth date and age|1970|08|22}}
| birth_place = Bangladesh
| birth_place = Bangladesh
| occupation = Divisional Head, Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University
⚫
| spouse = 1
| children = 2
| spouse =
| children =
⚫
| parents =
}}
}}
'''Mamun Al Mahtab''' ([[nickname]]: '''Shwapnil'''; born 22 August 1970) is a Bangladeshi doctor, hepatologist, medical scientist, and author. With 290 publications in national and international peer-reviewed journals to his credit, Mahtab is currently working as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).
'''Mamun Al Mahtab''' ([[nickname]]: '''Shwapnil'''; born 22 August 1970) is a Bangladeshi doctor, hepatologist, medical scientist, and author. With 290 publications in national and international peer-reviewed journals to his credit, Mahtab is currently working as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).


Mahtab is the chief researcher, and investigator for the GBPD060 clinical study of the Bangladesh-developed SARS-CoV-2 mRNA candidate. He is also the lead researcher on NASVAC's Phase I/II and III clinical studies.<ref>{{Cite journal |last=Clinical Research Organization, Dhaka, Bangladesh|date=2012-12-11|title=Phase IIII Study of a Therapeutic Vaccine Candidate Containing Hepatitis B Virus (HBV) Core Antigen (HBcAg) and HBV Surface Antigen (HBsAg) for Treatment of Patients With Chronic HBV Infection|url=https://clinicaltrials.gov/ct2/show/NCT01374308|website=ClinicalTrials.gov}}</ref> Mahtab was jointly awarded the ‘Premio Nacional' from the Cuban Academy of Sciences for the discovery of NASVAC<ref name=":3">{{Cite journal|last1=Al Mahtab|first1=Mamun|last2=Akbar|first2=Sheikh Mohammad Fazle|last3=Aguilar|first3=Julio Cesar|last4=Guillen|first4=Gerardo|last5=Penton|first5=Euduaro|last6=Tuero|first6=Angela|last7=Yoshida|first7=Osamu|last8=Hiasa|first8=Yoichi|last9=Onji|first9=Morikazu|date=2018|title=Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)|journal=PLOS ONE|volume=13|issue=8|pages=e0201236|doi=10.1371/journal.pone.0201236|issn=1932-6203|pmc=6104936|pmid=30133478|bibcode=2018PLoSO..1301236A|doi-access=free}}</ref> in 2019. He organizes awareness-raising programs on liver diseases across the country in addition to inventing the NASVAC<ref name=":3" /> drug aiming to offer an effective solution to Hepatitis B at an affordable price for mass people in Bangladesh.
Mahtab is the chief researcher, and investigator for the GBPD060 clinical study of the Bangladesh-developed SARS-CoV-2 mRNA candidate. He is also the lead researcher on NASVAC's Phase I/II and III clinical studies.<ref>{{Cite journal |last=Clinical Research Organization, Dhaka, Bangladesh|date=2012-12-11|title=Phase IIII Study of a Therapeutic Vaccine Candidate Containing Hepatitis B Virus (HBV) Core Antigen (HBcAg) and HBV Surface Antigen (HBsAg) for Treatment of Patients With Chronic HBV Infection|url=https://clinicaltrials.gov/ct2/show/NCT01374308|website=ClinicalTrials.gov}}</ref> Mahtab was jointly awarded the ‘Premio Nacional' from the Cuban Academy of Sciences for the discovery of NASVAC<ref name=":3">{{Cite journal|last1=Al Mahtab|first1=Mamun|last2=Akbar|first2=Sheikh Mohammad Fazle|last3=Aguilar|first3=Julio Cesar|last4=Guillen|first4=Gerardo|last5=Penton|first5=Euduaro|last6=Tuero|first6=Angela|last7=Yoshida|first7=Osamu|last8=Hiasa|first8=Yoichi|last9=Onji|first9=Morikazu|date=2018|title=Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)|journal=PLOS ONE|volume=13|issue=8|pages=e0201236|doi=10.1371/journal.pone.0201236|issn=1932-6203|pmc=6104936|pmid=30133478|bibcode=2018PLoSO..1301236A|doi-access=free}}</ref> in 2019. He organizes awareness-raising programs on liver diseases across the country in addition to inventing the NASVAC<ref name=":3" /> drug aiming to offer an effective solution to Hepatitis B at an affordable price for mass people in Bangladesh.

He has been subject to accusations and lawsuits of medical malpractice and negligence that led to patients' deaths.<ref>{{Cite web |title=Where is the accountability in Bangladesh’s healthcare? |url=https://www.dhakatribune.com/opinion/longform/344167/where-is-the-accountability-in-bangladesh%E2%80%99s |access-date=2024-04-17 |website= Dhaka Tribune {{!}} The Most Popular Outspoken English Daily in Bangladesh |language=en}}</ref><ref name=":5">[https://www.dhakatribune.com/bangladesh/339939/death-after-endoscopy-family-alleges-negligence Death after endoscopy: Family alleges negligence, doctor blames missing records] (dhakatribune.com)</ref>


==Education==
==Education==
Mahtab graduated from [[Mymensingh Medical College]] in 1995. He was awarded an MSc in [[Gastroenterology]] from the [[University of London]] in 1998 and was subsequently awarded an MD in [[Hepatology]] at [[Bangabandhu Sheikh Mujib Medical University]] in 2006. He is a Fellow of the [[Royal College of Physicians of London]], the [[Royal College of Physicians of Ireland]], the Indian College of Physicians and the American College of Gastroenterology.{{citation needed|date=March 2024}}
Mahtab graduated from [[Mymensingh Medical College]] in 1995. He was awarded an MSc in [[Gastroenterology]] from the [[University of London]] in 1998 and was subsequently awardeda n MD in [[Hepatology]] at [[Bangabandhu Sheikh Mujib Medical University]] in 2006. He is a Fellow of the [[Royal College of Physicians of London]], the [[Royal College of Physicians of Ireland]], the Indian College of Physicians and the American College of Gastroenterology.{{citation needed|date=March 2024}}


==Career==
==Career==
Line 24: Line 25:


He is currently associated with [[Anwar Khan Modern Hospital Limited|Anwer Khan Modern Hospital Limited]], Dhaka<ref>{{Cite web |date=2022-01-27 |title=Prof Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023] |url=https://doctorsgallery.org/prof-dr-mamun-al-mahtab-shwapnil/ |access-date=2023-09-29 |language=en-US}}</ref> and Labaid Specialized Hospital, Dhanmondi.<ref>{{Cite web |date=2021-12-31 |title=Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023] |url=https://doctorsgallery.org/dr-mamun-al-mahtab-shwapnil/ |access-date=2023-09-29 |language=en-US}}</ref> He also serves at Anwer Khan Modern Medical College Hospital as a Specialist Hepatologist & Gastroenterologist and at Labaid Specialized Hospital, Dhanmondi as a Liver & Liver Cancer Specialist & Interventional Endoscopist Divisional Head.<ref name=":0">{{Cite web |date=2024-01-09 |title=Prof. Dr. Mamun Al Mahtab Shwapnil |url=https://wheresmydoctor.com/listing/prof-dr-mamun-al-mahtab-shwapnil/ |access-date=2024-02-14 |website=Where's My Doctor? |language=en-US}}</ref>
He is currently associated with [[Anwar Khan Modern Hospital Limited|Anwer Khan Modern Hospital Limited]], Dhaka<ref>{{Cite web |date=2022-01-27 |title=Prof Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023] |url=https://doctorsgallery.org/prof-dr-mamun-al-mahtab-shwapnil/ |access-date=2023-09-29 |language=en-US}}</ref> and Labaid Specialized Hospital, Dhanmondi.<ref>{{Cite web |date=2021-12-31 |title=Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023] |url=https://doctorsgallery.org/dr-mamun-al-mahtab-shwapnil/ |access-date=2023-09-29 |language=en-US}}</ref> He also serves at Anwer Khan Modern Medical College Hospital as a Specialist Hepatologist & Gastroenterologist and at Labaid Specialized Hospital, Dhanmondi as a Liver & Liver Cancer Specialist & Interventional Endoscopist Divisional Head.<ref name=":0">{{Cite web |date=2024-01-09 |title=Prof. Dr. Mamun Al Mahtab Shwapnil |url=https://wheresmydoctor.com/listing/prof-dr-mamun-al-mahtab-shwapnil/ |access-date=2024-02-14 |website=Where's My Doctor? |language=en-US}}</ref>


=== Lawsuits ===
Dr. Mahtab has been the subject of numerous complaints and legal cases alleging negligence and mistreatment of patients. These allegations have raised concerns within the medical community and among patients regarding the quality of care provided by Dr. Mahtab. The controversies surrounding Dr. Mahtab's practices have garnered significant attention and scrutiny, prompting discussions about medical ethics, patient safety, and regulatory oversight in healthcare. In May 2021, a Dhaka court ordered an investigation into allegations of negligence against three doctors, including Dr. Mamun Al Mahtab, leading to the death of another physician, Dr. Toufiq Enam. Physiotherapist Aktaruzzaman Mia filed a case with the Chief Metropolitan Magistrate's Court regarding the death of his son, Dr. Enam, on May 30 while undergoing treatment at BRB Hospital. Dr. Mahtab, a gastroenterologist at Labaid Hospital, was one of the three accused doctors. According to the allegations, Dr. Mahtab conducted an endoscopic retrograde cholangiopancreatography (ERCP) procedure on Dr. Enam after he developed complications following a surgery at Islami Bank Hospital. Dr. Mahtab admitted to treating Dr. Enam for hepatitis B and performing the ERCP with the patient's consent to avoid further surgery's high costs and risks. However, Dr. Enam's condition deteriorated, and he was transferred to BRB Hospital, where he passed away during an operation. Dr. Mahtab denied any negligence, claiming he was unaware of Dr. Enam's pre-existing conditions.<ref>{{Cite web |last=Correspondent |first=Court |title=Three doctors charged with negligence in the death of another physician |url=https://bdnews24.com/bangladesh/three-doctors-charged-with-negligence-in-the-death-of-another-physician |access-date=2024-02-22 |website=bdnews24.com |language=en}}</ref><ref>{{Cite web |title=Case filed against three doctors over physician’s death |url=https://www.newagebd.net/article/141349/case-filed-against-three-doctors-over-physicians-death |access-date=2024-02-22 |website=New Age {{!}} The Most Popular Outspoken English Daily in Bangladesh |language=en}}</ref>


In March 2024, Khairul Bashar filed a formal complaint with the Minister of Health and Family Welfare, Dr. Samanta Lal Sen, urging an investigation into Mahtab and Labaid concerning the death of his brother in November 2023. According to the complaint, the patient Afsar Ahmed underwent an endoscopy procedure<ref>https://www.rtvonline.com/capital/266552</ref> conducted by Mahtab at Labaid and passed away on the same day due to alleged medical mismanagement, inefficiency, negligence, and carelessness.<ref>https://bangla.bdnews24.com/health/sydqmlxkv1</ref><ref>https://bangladeshmoments.com/health/123426/%E0%A6%AB%E0%A7%87%E0%A6%B0-%E0%A6%8F%E0%A6%A8%E0%A7%8D%E0%A6%A1%E0%A7%8B%E0%A6%B8%E0%A7%8D%E0%A6%95%E0%A6%AA%E0%A6%BF-%E0%A6%95%E0%A6%B0%E0%A6%BE%E0%A6%A4%E0%A7%87-%E0%A6%97%E0%A6%BF%E0%A7%9F%E0%A7%87-%E0%A6%AE%E0%A7%83%E0%A6%A4%E0%A7%8D%E0%A6%AF%E0%A7%81%E0%A6%B0-%E0%A6%85%E0%A6%AD%E0%A6%BF%E0%A6%AF%E0%A7%8B%E0%A6%97-%E0%A6%B2%E0%A7%8D%E0%A6%AF%E0%A6%BE%E0%A6%AC%E0%A6%8F%E0%A6%87%E0%A6%A1%E0%A7%87%E0%A6%B0-%</ref>

In February 2024, Raahib Reza, a 31-year-old patient, passed away at Labaid Dhanmondi Hospital ICU, after undergoing a routine endoscopy procedure performed by Mahtab. Allegations surfaced from the patient's family, asserting that his medical history and pre-assessment tests were not duly reviewed <ref>https://www.newagebd.net/article/225950/patient-dies-at-labaid-for-alleged-maltreatment</ref> before sedation was administered which was clearly mentioned as not advisable in hos pre-operative test reports.<ref>https://www.thereport.live/legal/it-professional-dies-after-endoscopy-at-labaid-hospital/28419</ref> which ultimately caused his demise.<ref>https://www.tbsnews.net/bangladesh/family-seek-justice-patients-death-labaid-hospital-800002</ref> Moreover, the family accused Mahtab and Labaid of lacking transparency regarding the certified healthcare professional responsible for administering the sedative. Subsequently, the patient's family took legal action by filing a writ petition with the High Court, seeking the revocation of Mahtab and Labaid's licenses and compensation for what they deemed gross medical negligence.<ref>https://www.dhakatribune.com/bangladesh/court/341520/writ-seeks-cancellation-of-dhanmondi-labaid%E2%80%99s</ref><ref>https://www.dhakatribune.com/bangladesh/339939/death-after-endoscopy-family-alleges-negligence</ref> Responding to the petition, the High Court directed the government to establish an independent committee to investigate the allegations of gross medical negligence.<ref>https://www.daily-sun.com/post/738771</ref><ref>
https://www.thedailystar.net/health/news/raahib-rezas-death-labaid-hc-orders-form-committee-probe-negligence-3565236</ref><ref>https://dailycountrytodaybd.com/story/doctor%27s-negligent-on-death-and-its-legal-remedies
</ref> Furthermore, the High Court inquired about the need for establishing a medical board to address instances of medical negligence.<ref> https://bangladeshpost.net/posts/medical-errors-kill-people-132197</ref><ref>
https://www.thedailystar.net/opinion/views/news/the-grave-irony-medical-negligence-causing-deaths-3550876
</ref>


=== Research ===
=== Research ===
Mahtab is the principal investigator of the phase I/II and III clinical trials of NASVAC,<ref name="auto1">{{Cite journal|last1=Al Mahtab|first1=Mamun|last2=Akbar|first2=Sheikh Mohammad Fazle|last3=Aguilar|first3=Julio Cesar|last4=Guillen|first4=Gerardo|last5=Penton|first5=Euduaro|last6=Tuero|first6=Angela|last7=Yoshida|first7=Osamu|last8=Hiasa|first8=Yoichi|last9=Onji|first9=Morikazu|year=2018|title=Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)|journal=PLOS ONE|volume=13|issue=8|pages=e0201236|bibcode=2018PLoSO..1301236A|doi=10.1371/journal.pone.0201236|pmid=30133478|pmc=6104936|doi-access=free}}</ref><ref>{{Cite journal|title=Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)|journal=PLOS ONE|volume=13|issue=8|pages=e0201236|pmc = 6104936|year=2018|last1=Al Mahtab|first1=M.|last2=Akbar|first2=S. M.|last3=Aguilar|first3=J. C.|last4=Guillen|first4=G.|last5=Penton|first5=E.|last6=Tuero|first6=A.|last7=Yoshida|first7=O.|last8=Hiasa|first8=Y.|last9=Onji|first9=M.|pmid=30133478|doi=10.1371/journal.pone.0201236|bibcode=2018PLoSO..1301236A|doi-access=free}}</ref><ref>{{Cite news |url=https://www.dhakatribune.com/health/2017/10/25/bangladeshi-researchers-develop-advanced-drug-hepatitis-b|title=Bangladeshi researchers develop advanced drug for Hepatitis B|date=2017-10-25|work=Dhaka Tribune}}</ref><ref>{{Cite journal|title=Europe PMC|url=https://europepmc.org/article/med/19073404|access-date=2021-08-17|journal=Hepatobiliary & Pancreatic Diseases International |year=2008|pmid=19073404|last1=Mahtab|first1=M. A.|last2=Rahman|first2=S.|last3=Karim|first3=M. F.|last4=Khan|first4=M.|last5=Foster|first5=G.|last6=Solaiman|first6=S.|last7=Afroz|first7=S.|volume=7|issue=6|pages=595–600}}</ref> a new generic for chronic hepatitis B, which is already registered in Bangladesh, Cuba, Nicaragua, Ecuador, Belarus and Angola. It is the first drug to be developed and registered in Bangladesh. NASVAC is also the ‘first novel molecule’ to be registered by the Directorate General of Drug Administration of the Bangladesh Government.{{Citation needed|date=February 2024}}
Mahtab is the principal investigator of the phase I/II and III clinical trials of NASVAC,<ref name="auto1">{{Cite journal|last1=Al Mahtab|first1=Mamun|last2=Akbar|first2=Sheikh Mohammad Fazle|last3=Aguilar|first3=Julio Cesar|last4=Guillen|first4=Gerardo|last5=Penton|first5=Euduaro|last6=Tuero|first6=Angela|last7=Yoshida|first7=Osamu|last8=Hiasa|first8=Yoichi|last9=Onji|first9=Morikazu|year=2018|title=Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)|journal=PLOS ONE|volume=13|issue=8|pages=e0201236|bibcode=2018PLoSO..1301236A|doi=10.1371/journal.pone.0201236|pmid=30133478|pmc=6104936|doi-access=free}}</ref><ref>{{Cite journal|title=Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)|journal=PLOS ONE|volume=13|issue=8|pages=e0201236|pmc = 6104936|year=2018|last1=Al Mahtab|first1=M.|last2=Akbar|first2=S. M.|last3=Aguilar|first3=J. C.|last4=Guillen|first4=G.|last5=Penton|first5=E.|last6=Tuero|first6=A.|last7=Yoshida|first7=O.|last8=Hiasa|first8=Y.|last9=Onji|first9=M.|pmid=30133478|doi=10.1371/journal.pone.0201236|bibcode=2018PLoSO..1301236A|doi-access=free}}</ref><ref>{{Cite news |url=https://www.dhakatribune.com/health/2017/10/25/bangladeshi-researchers-develop-advanced-drug-hepatitis-b|title=Bangladeshi researchers develop advanced drug for Hepatitis B|date=2017-10-25|work=Dhaka Tribune}}</ref><ref>{{Cite journal|title=Europe PMC|url=https://europepmc.org/article/med/19073404|access-date=2021-08-17|journal=Hepatobiliary & Pancreatic Diseases International |year=2008|pmid=19073404|last1=Mahtab|first1=M. A.|last2=Rahman|first2=S.|last3=Karim|first3=M. F.|last4=Khan|first4=M.|last5=Foster|first5=G.|last6=Solaiman|first6=S.|last7=Afroz|first7=S.|volume=7|issue=6|pages=595–600}}</ref> a new generic for chronic hepatitis B, which is already registered in Bangladesh, Cuba, Nicaragua, Ecuador, Belarus and Angola. It is the first drug to be developed and registered in Bangladesh. NASVAC is also the ‘first novel molecule’ to be registered by the Directorate General of Drug Administration of the Bangladesh Government.<ref>{{Cite web |title=Medical conference dedicated to Bangabandhu begins today |url=https://bangladeshpost.net/posts/medical-conference-dedicated-to-bangabandhu-begins-today-23786 |access-date=2024-02-26 |website=bangladeshpost.net |language=en}}</ref>


=== Publications ===
=== Publications ===

Revision as of 12:20, 3 May 2024

Mamun Al Mahtab
Head and shoulders photo of Mamun Al Mahtab
Al Mahtab in 2021
Born (1970-08-22) August 22, 1970 (age 53)
Bangladesh
Occupation(s)Divisional Head, Interventional Hepatology Division, Bangabandhu Sheikh Mujib Medical University

Mamun Al Mahtab (nickname: Shwapnil; born 22 August 1970) is a Bangladeshi doctor, hepatologist, medical scientist, and author. With 290 publications in national and international peer-reviewed journals to his credit, Mahtab is currently working as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).

Mahtab is the chief researcher, and investigator for the GBPD060 clinical study of the Bangladesh-developed SARS-CoV-2 mRNA candidate. He is also the lead researcher on NASVAC's Phase I/II and III clinical studies.[1] Mahtab was jointly awarded the ‘Premio Nacional' from the Cuban Academy of Sciences for the discovery of NASVAC[2] in 2019. He organizes awareness-raising programs on liver diseases across the country in addition to inventing the NASVAC[2] drug aiming to offer an effective solution to Hepatitis B at an affordable price for mass people in Bangladesh.

Education

Mahtab graduated from Mymensingh Medical College in 1995. He was awarded an MSc in Gastroenterology from the University of London in 1998 and was subsequently awardeda n MD in Hepatology at Bangabandhu Sheikh Mujib Medical University in 2006. He is a Fellow of the Royal College of Physicians of London, the Royal College of Physicians of Ireland, the Indian College of Physicians and the American College of Gastroenterology.[citation needed]

Career

Mahtab is currently working as the Head, Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University (BSMMU).[3]

He is currently associated with Anwer Khan Modern Hospital Limited, Dhaka[4] and Labaid Specialized Hospital, Dhanmondi.[5] He also serves at Anwer Khan Modern Medical College Hospital as a Specialist Hepatologist & Gastroenterologist and at Labaid Specialized Hospital, Dhanmondi as a Liver & Liver Cancer Specialist & Interventional Endoscopist Divisional Head.[3]

Research

Mahtab is the principal investigator of the phase I/II and III clinical trials of NASVAC,[6][7][8][9] a new generic for chronic hepatitis B, which is already registered in Bangladesh, Cuba, Nicaragua, Ecuador, Belarus and Angola. It is the first drug to be developed and registered in Bangladesh. NASVAC is also the ‘first novel molecule’ to be registered by the Directorate General of Drug Administration of the Bangladesh Government.[10]

Publications

Mahtab has compiled six books, namely ‘Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases’, published by Elsevier (2009),[11] ’Comprehensive Text Book on Hepatitis B’, published by Jaypee (2010), ‘Fatty Liver Disease’ (2012) and 'Hepatitis Management Update' (2015) published by McMillan and 'Text Book of Hepato-Gastroenterology' (2015) and 'Practical Hepato-Gastroenterology Prescriber' (2016) published by Jaypee.[12]

Mahtab is serving on the Editorial Boards of several international journals in the fields of Hepatology and Gastroenterology including,

  • Euro-Asian Journal of Hepato-Gastroenterology (Journal of Euro-Asian Gastroenterological Association) (Co-Editor-in-Chief),[13]
  • Hepatology International (journal of Asian Pacific Association for the Study of the Liver) (Associate Editor)[14]
  • Journal of Clinical, Experimental Hepatology (journal of Indian Association for the Study of the Liver) (Editorial Board Member),[15]
  • Hepatitis B Annual (Kalinga Gastroenterology Foundation, India) (Co-Editor-in-Chief)[16] to name a few.

Affiliations

He is four times elected Secretary General of Association for the Study of the Liver Diseases Bangladesh (ASLDB) (the national Hepatology Association of Bangladesh).[17] He is also foundering President of Bangabandhu Sheikh Mujib Medical University Hepatology Alumni Association[18] and Executive Chairman of Forum for the Study of the Liver Bangladesh.[19]

He is the founder General Secretary of Bangladesh Stem Cell and Regenerative Medicine Society.[20]

He has organized several ‘first time in Bangladesh’ medical conferences including the first STEMCON in 2017 (1st international conference on stem cell therapy in Bangladesh) and first EndoVasculoCon in 2019 (1st live conference from endoscopy suit and vascular lab in the region).[21]

He is Member Secretary of Sampritee Bangladesh.[22]

References

  1. ^ Clinical Research Organization, Dhaka, Bangladesh (2012-12-11). "Phase IIII Study of a Therapeutic Vaccine Candidate Containing Hepatitis B Virus (HBV) Core Antigen (HBcAg) and HBV Surface Antigen (HBsAg) for Treatment of Patients With Chronic HBV Infection". ClinicalTrials.gov.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ a b Al Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Aguilar, Julio Cesar; Guillen, Gerardo; Penton, Euduaro; Tuero, Angela; Yoshida, Osamu; Hiasa, Yoichi; Onji, Morikazu (2018). "Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)". PLOS ONE. 13 (8): e0201236. Bibcode:2018PLoSO..1301236A. doi:10.1371/journal.pone.0201236. ISSN 1932-6203. PMC 6104936. PMID 30133478.
  3. ^ a b "Prof. Dr. Mamun Al Mahtab Shwapnil". Where's My Doctor?. 2024-01-09. Retrieved 2024-02-14.
  4. ^ "Prof Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023]". 2022-01-27. Retrieved 2023-09-29.
  5. ^ "Dr Mamun Al Mahtab Shwapnil - Appointment Process [Updated 2023]". 2021-12-31. Retrieved 2023-09-29.
  6. ^ Al Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Aguilar, Julio Cesar; Guillen, Gerardo; Penton, Euduaro; Tuero, Angela; Yoshida, Osamu; Hiasa, Yoichi; Onji, Morikazu (2018). "Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)". PLOS ONE. 13 (8): e0201236. Bibcode:2018PLoSO..1301236A. doi:10.1371/journal.pone.0201236. PMC 6104936. PMID 30133478.
  7. ^ Al Mahtab, M.; Akbar, S. M.; Aguilar, J. C.; Guillen, G.; Penton, E.; Tuero, A.; Yoshida, O.; Hiasa, Y.; Onji, M. (2018). "Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)". PLOS ONE. 13 (8): e0201236. Bibcode:2018PLoSO..1301236A. doi:10.1371/journal.pone.0201236. PMC 6104936. PMID 30133478.
  8. ^ "Bangladeshi researchers develop advanced drug for Hepatitis B". Dhaka Tribune. 2017-10-25.
  9. ^ Mahtab, M. A.; Rahman, S.; Karim, M. F.; Khan, M.; Foster, G.; Solaiman, S.; Afroz, S. (2008). "Europe PMC". Hepatobiliary & Pancreatic Diseases International. 7 (6): 595–600. PMID 19073404. Retrieved 2021-08-17.
  10. ^ "Medical conference dedicated to Bangabandhu begins today". bangladeshpost.net. Retrieved 2024-02-26.
  11. ^ Mahtab, Mamun-Al (2009-12-15). Liver: A Complete Book on Hepato-Pancreato-Biliary Diseases - E-Book. Elsevier Health Sciences. ISBN 978-81-312-3157-9.
  12. ^ Akbar, Sk. Md. Fazle; Kumar, Parveen June (30 November 2014). Mahtab, Mamun Al (ed.). Textbook of Hepato-Gastroenterology. Jaypee Brothers Medical Publishers Pvt. Limited. pp. https://www.google.com.bd/books/edition/Textbook_of_Hepato_Gastroenterology/zyjFoQEACAAJ?hl=en. ISBN 9789351523789.{{cite book}}: CS1 maint: date and year (link)
  13. ^ "EUROASIAN JOURNAL OF HEPATO-GASTROENTEROLOGY". Euroasian Journal of Hepato-Gastroenterology. 11.
  14. ^ "Hepatology International". Hepatology International. 15.
  15. ^ "Journal of Clinical and Experimental Hepatology". Journal of Clinical and Experimental Hepatology.
  16. ^ "Hepatitis B Annual".
  17. ^ "Association for the Study of Liver Diseases Bangladesh". asldb.
  18. ^ "Hepatology Alumni Association of BSMMU launched, Prof Swapnil president". bdnews24.
  19. ^ "Forum for the Study of the Liver Bangladesh". liverforum.
  20. ^ স্টেম সেল থেরাপি: সফল এক আবিষ্কার. sarabangla (in Bengali). 2017-12-26.
  21. ^ ঢাকায় অনুষ্ঠিত হল বিশ্বের প্রথম এন্ডোভাস্কুলোকন সম্মেলন. khobor71 (in Bengali).
  22. ^ "Sampriti Bangladesh meets Sri Lankan envoy, condemns bombing attacks". bdnews24.com. Retrieved 2021-08-17.
source: https://en.wikipedia.org/w/index.php?title=Mamun_Al_Mahtab&diff=prev&oldid=1222023261